Skip to Main Content

Author Details

Kun-Hsing Yu
Harvard Medical School
2011
57
18
PMIDPaper TitleJournal TitlePublished Year
36828138Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.J Am Acad Dermatol2023
37121095Identifying shared genetic architecture between rheumatoid arthritis and other conditions: a phenome-wide association study with genetic risk scores.EBioMedicine2023
37055393Histopathology images predict multi-omics aberrations and prognoses in colorectal cancer patients.Nat Commun2023
37421953Machine learning for cryosection pathology predicts the 2021 WHO classification of glioma.Med2023
37246892Large-scale real-world data analyses of cancer risks among patients with rheumatoid arthritis.Int J Cancer2023
37301916Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data.NPJ Precis Oncol2023
36736626Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.J Am Acad Dermatol2023
35330688Outdoor mass gathering events and SARS-CoV-2 infection in Catalonia (North-East Spain).Lancet Reg Health Eur2022
35410453Large-scale real-world data analysis identifies comorbidity patterns in schizophrenia.Transl Psychiatry2022
35608378Survival Prediction After Neurosurgical Resection of Brain Metastases: A Machine Learning Approach.Neurosurgery2022
35604679Association of Race and Socioeconomic Disadvantage With Missed Telemedicine Visits for Pediatric Patients During the COVID-19 Pandemic.JAMA Pediatr2022
36437503Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor-infiltrating lymphocyte levels.Clin Transl Med2022
36425793The impact of stage-related features in melanoma recurrence prediction: A machine learning approach.JAAD Int2022
36316482Prediction of early-stage melanoma recurrence using clinical and histopathologic features.NPJ Precis Oncol2022
33140578Prolonged Auditory Brainstem Response in Universal Hearing Screening of Newborns with Autism Spectrum Disorder.Autism Res2021
33597541Temporal bias in case-control design: preventing reliable predictions of the future.Nat Commun2021
33789879Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA.J Immunother Cancer2021
33722896Development of a Histopathology Informatics Pipeline for Classification and Prediction of Clinical Outcomes in Subtypes of Renal Cell Carcinoma.Clin Cancer Res2021
34777251Quantifying the Impacts of Pre- and Post-Conception TSH Levels on Birth Outcomes: An Examination of Different Machine Learning Models.Front Endocrinol (Lausanne)2021
34508179Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types.NPJ Precis Oncol2021
34845230Integrative multiomics-histopathology analysis for breast cancer classification.NPJ Breast Cancer2021
34312463Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks.Sci Rep2021
31562770Examining the Use of Real-World Evidence in the Regulatory Process.Clin Pharmacol Ther2020
33288536COVID-19 infections following physical school reopening.Arch Dis Child2020
32807164Deciphering serous ovarian carcinoma histopathology and platinum response by convolutional neural networks.BMC Med2020
32755895Reproducible Machine Learning Methods for Lung Cancer Detection Using Computed Tomography Images: Algorithm Development and Validation.J Med Internet Res2020
32364237Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.J Am Med Inform Assoc2020
32348367Deep learning in rare disease. Detection of tubers in tuberous sclerosis complex.PLoS One2020
31356677Autoimmune Effects of Lung Cancer Immunotherapy Revealed by Data-Driven Analysis on a Nationwide Cohort.Clin Pharmacol Ther2020
30291179Framing the challenges of artificial intelligence in medicine.BMJ Qual Saf2019
31211337Suicide Rates Among Adolescents and Young Adults in the United States, 2000-2017.JAMA2019
31069578Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting.Cancer Causes Control2019
31040396Evaluation of the association of bariatric surgery with subsequent depression.Int J Obes (Lond)2019
31121113Evaluation of Taroni et al.: Understanding Rare Diseases by MultiPLIER.Cell Syst2019
30606829Challenging transitions.Science2019
28968749Omics AnalySIs System for PRecision Oncology (OASISPRO): a web-based omics analysis tool for clinical phenotype prediction.Bioinformatics2018
30094994A Cloud-Based Metabolite and Chemical Prioritization System for the Biology/Disease-Driven Human Proteome Project.J Proteome Res2018
29954971Education for the future.Science2018
30333165Data-driven analyses revealed the comorbidity landscape of tuberous sclerosis complex.Neurology2018
29505266Systematic Protein Prioritization for Targeted Proteomics Studies through Literature Mining.J Proteome Res2018
27497798Biomedical informatics advancing the national health agenda: the AMIA 2015 year-in-review in clinical and consumer informatics.J Am Med Inform Assoc2017
29153840Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma.Cell Syst2017
28983033Promoting human rights through science.Science2017
28684488Artificial intelligence in research.Science2017
27897013HARNESSING BIG DATA FOR PRECISION MEDICINE: INFRASTRUCTURES AND APPLICATIONS.Pac Symp Biocomput2017
27099341Omics Profiling in Precision Oncology.Mol Cell Proteomics2016
27606461A survival guide for interdisciplinary PhD students.Nat Biotechnol2016
27527408Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features.Nat Commun2016
27545504Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro.Cell Stem Cell2016
27312948Predicting Ovarian Cancer Patients' Clinical Response to Platinum-Based Chemotherapy by Their Tumor Proteomic Signatures.J Proteome Res2016
  • 1 - 50 of 57

Recommended Authors

Thomas Yu
Career Start Year 2017
Number of shared co-authors 1
James Zou
Stanford University
Career Start Year 2016
Number of shared co-authors 3
Osvaldo Espin-Garcia
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 0
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 3
Anna Goldenberg
SickKids Research Institute
Career Start Year 2011
Number of shared co-authors 2
Subha Madhavan
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Career Start Year 2009
Number of shared co-authors 1
Jihoon Kim
university of california san diego
Career Start Year 2009
Number of shared co-authors 2
Stephen R Piccolo
Brigham Young University
Career Start Year 2008
Number of shared co-authors 0
Kahn Rhrissorrakrai
T.J. Watson Research Center
Career Start Year 2008
Number of shared co-authors 2
Yiqing Zhao
Northwestern University
Career Start Year 2008
Number of shared co-authors 0
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 0
Yuanfang Guan
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 5
Justin Guinney
University of Washington
Career Start Year 2006
Number of shared co-authors 1
Joel T Dudley
Institute for Next Generation Healthcare
Career Start Year 2006
Number of shared co-authors 4
Marco Chierici
Fondazione Bruno Kessler
Career Start Year 2006
Number of shared co-authors 0
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 0
Guanghua Xiao
The University of Texas Southwestern Medical Center
Career Start Year 2005
Number of shared co-authors 0
Richard A Moffitt
Stony Brook University, and Stony Brook Cancer Center
Career Start Year 2005
Number of shared co-authors 2
May D Wang
Georgia Institute of Technology
Career Start Year 2003
Number of shared co-authors 1
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Gil Alterovitz
Brigham and Women's Hospital
Career Start Year 2002
Number of shared co-authors 1
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 1
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 1
Jiang Bian
College of Medicine, University of Florida
Career Start Year 2001
Number of shared co-authors 0
Jeffrey S Morris
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 5
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 0
Atul J Butte
Bakar Computational Health Sciences Institute, University of California san francisco
Career Start Year 1993
Number of shared co-authors 4
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
Warren A Kibbe
Duke Clinical Research Institute, Duke University
Career Start Year 1987
Number of shared co-authors 2
Yves A Lussier
Center for Biomedical Informatics and Biostatistics, University of Arizona
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Isaac S Kohane
Harvard Medical School
Co-authored papers 19
Michael Snyder
Stanford University
Co-authored papers 13
Nathan Palmer
Harvard Medical School
Co-authored papers 7
Jung-Hsien Chiang
National Cheng Kung University
Co-authored papers 4
Russ B Altman
Stanford University
Co-authored papers 4
Yu-Ju Chen
Institute of Chemistry
Co-authored papers 4
Katherine P Liao
Co-authored papers 3
Andrew T Chan
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 3
Gerald J Berry
Co-authored papers 3
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 2
Ken Dutton-Regester
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Tianxi Cai
Harvard T.H. Chan School of Public Health
Co-authored papers 2
Peter K Sorger
Co-authored papers 2
Daniel W Chan
Division of Clinical Chemistry, Johns Hopkins University
Co-authored papers 2
Iv??n S??nchez Fern??ndez
Boston Medical Center, Boston University School of Medicine
Co-authored papers 2
Douglas A Levine
Perlmutter Cancer Center
Co-authored papers 2
Zhen Zhang
Co-authored papers 2
Omar Arnaout
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 2
Mustafa Sahin
Harvard Medical School
Co-authored papers 2
Brett K Beaulieu-Jones
University of Chicago
Co-authored papers 2
Jingjing Li
Co-authored papers 2
Hui Zhang
Co-authored papers 2
Daniel L Rubin
Stanford University.
Co-authored papers 2
Stephen C J Parker
University of Michigan ann arbor
Co-authored papers 1
Nancy U Lin
Co-authored papers 1
Marta Amengual-Gual
Hospital Universitari Son Llatzer, Universitat de les Illes Balears
Co-authored papers 1
Rebecca Hazen
University of Washington.
Co-authored papers 1
Lisiane Pruinelli
College of Nursing, University of Florida
Co-authored papers 1
Joost J C Verhoeff
University Medical Center Utrecht
Co-authored papers 1
Tara Hiltke
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 1
Release 1.2